Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis

Clinical trial NCT01682512 · TERMINATED

Trial details

NCT number: NCT01682512
Sponsor: Boehringer Ingelheim
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Arthritis, Rheumatoid

Start date: 2012-09-05
Primary completion: 2015-11-17
Enrollment: 294

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.